ALK c.953-63309T>C

Variant ID: 2-29818291-A-G

NM_004304.4(ALK):c.953-63309T>C

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.

Clinical Pharmacology And Therapeutics
Nicoletti, Paola P; Barrett, Sarah S; McEvoy, Laurence L; Daly, Ann K AK; Aithal, Guruprasad G; Lucena, M Isabel MI; Andrade, Raul J RJ; Wadelius, Mia M; Hallberg, Pär P; Stephens, Camilla C; Bjornsson, Einar S ES; Friedmann, Peter P; Kainu, Kati K; Laitinen, Tarja T; Marson, Anthony A; Molokhia, Mariam M; Phillips, Elizabeth E; Pichler, Werner W; Romano, Antonino A; Shear, Neil N; Sills, Graeme G; Tanno, Luciana K LK; Swale, Ashley A; Floratos, Aris A; Shen, Yufeng Y; Nelson, Matthew R MR; Watkins, Paul B PB; Daly, Mark J MJ; Morris, Andrew P AP; Alfirevic, Ana A; Pirmohamed, Munir M
Publication Date: 2019-11

Variant appearance in text: rs187926838
PubMed Link: 31066027
Variant Present in the following documents:
  • Main text
  • CPT-106-1028-s001.pdf
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs187926838
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page